ESCMID Global 2026 is approaching fast! Explore the many highlights in the scientific programme including:

• New ESCMID Mobile Lab sessions available for registration
• Selective Pressure team sign-ups are still open until 20 March
• The TAE Day programme is available, and the mailing list is open

Learn more about these new updates and much more on our website and be sure to sign up for the interactive workshops while seats last. Register today!

Science and Research

Our ESCMID Study Groups are constantly organising webinars exploring key topics or discoveries in their specific field. These online symposia are all free to join live and available on demand on ESCMID Media after.

Education

Explore current evidence, real-life case discussions, and global perspectives on pathogens that affect maternal and foetal outcomes, including TORCH infections, viral hepatitis, vector-borne and respiratory diseases.

Developed in alignment with the WHO NPD Road Map 2030 and current global health priorities, this course combines high-level theoretical instruction with extensive hands-on training in a state-of-the-art reference laboratory. Learn more and register today.

Congress and Events

Early registration is now open for the second edition of the Global AMR Innovators Conference (GAMRIC) which will take place 22-24 September 2026 in Lisbon, Portugal. Seats sold out last year so take advantage of the low rates and secure your spot at the conference. Additionally, abstract submission will open next week on 10 March.

Uncover a new understanding of human susceptibility to infectious diseases in this keynote lecture from Filomeen Haerynck. She will explain how genetic predispositions influence immune responses and the importance of considering host genetics in diagnosis and treatment, paving the way for more precise, personalised approaches to infectious disease management.

Guidelines and Journals

The ESCMID Emerging Infections Subcommittee supported a recent commentary on the history of dengue transmission, the current clinical relevance and the outlook for the future in Europe. You can read the full article published in CMI.

Global cholera activity intensified with 24K new cases and 275 deaths. Chikungunya rose among travellers from Seychelles, indicating ongoing transmission; risk for visitors is high, with increased activity also noted in Suriname and Bolivia. Measles still surges: the US reported 1K confirmed cases in 2026, mostly outbreak-linked, and outbreaks continue in Indonesia and DR Congo. Venezuela recorded 36 yellow fever cases and monkey epizootics, indicating sylvatic transmission.

Changes in nasal and throat microbiota composition during and after mupirocin and chlorhexidine decolonisation treatment in asymptomatic MRSA carriers: a longitudinal observational study

Approach to Dengue Fever